AVITA Medical, Inc. Financial Ratios — RCEL Stock

Profitability (AUD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	-25.79	-83.31	-124.03	-85.3	-149.2	-175.98	-302.99	-204.98	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-14.47	-52.4	-64.97	-51.93	-98.58	-109.6	-143.63	-111.71	-117.6	-77.66	-25.57	-23.83	-33.71	-64.64	-71.4
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	70.84	71.58	75.97	75	72.54	59.92	48.6	41.23	76.78	79.16	79.65	82.45	84.48	85.85	82.13
EBITDA Margin (%)	-160.6	-209.69	-335.99	-269.39	-290.53	-1,125.77	-1,414.67	-1,478.04	-461.44	-295.97	-88.34	-78.26	-83.81	-86.33	-56.12
Operating Margin (%)	-160.6	-209.69	-335.99	-269.39	-290.53	-1,134.12	-1,430.17	-1,489.88	-466.35	-299.23	-90.79	-79.91	-85.07	-88.08	-59.4
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-60.28	-231.47	-292.04	-248.18	-282.21	-1,122.13	-1,393.34	-1,486.44	-460.78	-294.65	-90.81	-77.36	-70.43	-96.17	-67.83
Profit Margin (%)	-57.58	-226.42	-287.49	-191.84	-258.44	-776.24	-1,277.05	-1,370.83	-458.57	-294.68	-90.94	-77.47	-70.56	-96.26	-67.85
Net Income to Common Margin (%)	-57.58	-226.42	-287.49	-191.84	-258.44	-776.24	-1,277.05	-1,370.83	-458.57	-294.68	-90.94	-77.47	-70.56	-96.26	-67.85
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-25.79	-83.31	-124.03	-85.3	-149.2	-175.98	-302.99	-204.98	- -	- -	- -	- -	- -	- -	- -

Credit (AUD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1	1	42	46	46
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	44
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1	- -	42	45	2
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.01	- -	-0.05	-0.03	-0.03	-1.01	-0.83	-1.15
Net Debt/EBITDA	2.53	1.17	1.12	0.5	0.03	0.37	0.3	0.79	0.8	1.74	4.29	0.67	-0.42	-0.51	-0.81
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.01	- -	-0.04	-0.03	-0.03	-0.99	-0.81	-1.08
Net Debt/EBIT	2.53	1.17	1.12	0.5	0.03	0.37	0.29	0.79	0.79	1.73	4.17	0.66	-0.41	-0.5	-0.77
EBITDA to Interest Expense	-415.31	-104,914.7	-103,936.12	-281.52	-614,626.1	-537,155.14	-999.81	-653.86	-935.52	-1,279.21	-1,173.86	-1,683.56	-36.77	-10.35	-8.03
EBITDA-CapEx/Interest Expense	-422.23	-106,043.52	-104,854.76	-284.46	-617,598.64	-539,454.61	-1,033.73	-671.24	-980.96	-1,304.88	-1,227.23	-1,716.38	-38.03	-12.09	-8.25
EBIT to Interest Expense	-415.31	-104,914.7	-103,936.12	-281.52	-614,626.1	-541,141.99	-1,010.76	-659.1	-945.48	-1,293.3	-1,206.36	-1,719.06	-37.32	-10.56	-8.5
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	5	5
Common Equity/Total Assets	72.47	46.58	57.77	66.18	65.89	59.93	33.75	61.73	-592.71	-236.36	-176.49	-267.22	-266.9	-451.39	-724.21
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.71	- -	2.65	0.76	0.36	84.63	1,002.11	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	0.94	- -	-0.99	-0.4	-0.12	-16.24	-14.37	-0.59
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.58	- -	2.32	0.7	0.31	37.19	56.56	3.79
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.71	- -	2.65	0.76	1.08	86.45	1,022.12	-276.56
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	0.94	- -	-0.99	-0.4	-0.35	-16.59	-14.65	-12.71
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.58	- -	2.32	0.7	0.93	37.99	57.69	81.66
Net Debt to Equity	-78.93	-96.22	-101.55	-66.01	-5.87	-60.88	-74.01	-78.03	-96.84	-101.71	-95.76	-21.43	36.07	626.69	-196.64
Net Debt/Capital (%)	-437,013.45	253.74	336.04	-306.23	-7.42	-423.93	315.13	3,069.18	11.66	27.62	33.42	6.49	-6.37	-8.6	-8.79
EBITDA	-5	-7	-9	-7	-6	-8	-10	-14	-25	-42	-26	-27	-42	-55	-40
EBITDA-CapEx	-5	-7	-9	-7	-6	-8	-10	-14	-26	-43	-27	-27	-43	-65	-41
Operating Income (Loss)	-5	-7	-9	-7	-6	-8	-10	-14	-26	-43	-27	-28	-43	-57	-43

Liquidity (AUD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	8.86	3.82	4.33	2.04	0.2	2.79	1.49	3.82	4.5	9.55	14.99	7.42	6.75	1.78	0.29
Current Ratio	10.33	4.9	5.21	4.02	4.33	4.86	2.86	5.74	5.38	10.17	16.42	8.18	7.88	2.83	0.57
Quick Ratio	9.77	4.5	4.82	3.47	1.43	3.95	2.3	5.22	4.93	9.88	16.05	7.88	7.35	2.37	0.44
CFO/Avg Current Liab	-2.28	-2.28	-3.26	-3.53	-4.89	-5.28	-4.03	-5.39	-5.25	-3.73	-3.43	-2.11	-3.18	-2.93	-0.75
Common Equity/Total Assets	72.47	46.58	57.77	66.18	65.89	59.93	33.75	61.73	-592.71	-236.36	-176.49	-267.22	-266.9	-451.39	-724.21
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.71	- -	2.65	0.76	0.36	84.63	1,002.11	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	0.94	- -	-0.99	-0.4	-0.12	-16.24	-14.37	-0.59
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.58	- -	2.32	0.7	0.31	37.19	56.56	3.79
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.71	- -	2.65	0.76	1.08	86.45	1,022.12	-276.56
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	0.94	- -	-0.99	-0.4	-0.35	-16.59	-14.65	-12.71
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.58	- -	2.32	0.7	0.93	37.99	57.69	81.66
CFO/Total Liabilities	-190.52	-193.7	-323.79	-411.78	-681.24	-453.53	-336.1	-439.14	-388.73	-226.09	-263.06	-141.16	-60.74	-65.07	-42.71
CFO/CapEx	-32.79	-55.12	-95.02	-97.37	-216.18	-164.4	-19.78	-35.51	-15.69	-26.86	-22.06	-36.36	-26.27	-5.24	-28.26
Altman's Z-Score	-8.19	1.18	0.22	-8.75	-11.08	-0.58	-10.43	3.04	57.11	49.7	35.96	7.35	1.3	-3.58	-12.08

Working Capital (AUD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	7.58	4.4	3.04	4.3	4.36	0.75	0.84	6.05	6.93	8.2	10.55	9.86	8.97	6.61	6.86
Days Sales Outstanding	48.13	82.94	119.87	84.79	83.67	489.87	432.2	60.32	52.65	44.52	34.61	37.02	40.69	55.25	53.19
Inventory Turnover	1.46	1.38	0.86	0.88	0.97	0.41	0.39	0.66	1.6	3.18	4.29	3.2	2.02	1.41	1.8
Days Inventory Outstanding	250.86	264.47	421.99	413.65	375.66	900.41	933.39	550.28	228.46	114.61	85.04	113.95	181.12	258.18	202.48
Accounts Payable Turnover	1.93	1.17	0.61	1.03	0.49	0.89	0.14	1.24	1.1	1.07	1.74	2.13	3.31	2.13	1.63
Accounts Payable Turnover Days	189.15	311.44	602.86	353.1	744.23	411.34	2,690.64	293.24	331.74	339.82	210.2	171.39	110.22	170.97	223.57
Cash Conversion Cycle	109.83	35.97	-61	145.34	-284.9	978.94	-1,325.05	317.36	-50.63	-180.7	-90.55	-20.41	111.58	142.45	32.11
Inventory to Cash Days	-202.73	-181.53	-302.12	-328.86	-292	-410.54	-501.2	-489.96	-175.8	-70.09	-50.43	-76.93	-140.43	-202.93	-149.29
Inventories	1	1	1	1	- -	1	1	1	1	1	2	2	6	7	7
Raw Materials	- -	- -	- -	- -	- -	- -	1	1	1	1	1	1	4	2	2
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	4	5
Other Inventory	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (AUD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	54	48	38	34	49	60	68	558	898	621	242	510	535	144
- Cash & Cash Equivalents	14	8	10	3	- -	3	3	11	20	74	111	18	22	14	10
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1	1	42	46	46
Enterprise Value	-14	46	38	35	34	45	57	57	538	826	511	164	464	545	172
Total Capital	14	5	7	5	3	4	2	11	-153	-193	-221	-262	-256	-314	-362
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	0.94	- -	-0.99	-0.4	-0.35	-16.59	-14.65	-12.71
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.01	0.09	0.08	0.27
EV/Sales	- -	13.41	14.73	13.8	15.91	60.43	82.43	61.25	98.3	57.91	17.47	4.76	9.25	8.49	2.4
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	54	48	38	34	49	60	68	558	898	621	242	510	535	144
Diluted Enterprise Value	-14	46	38	35	34	46	57	57	538	826	511	225	531	567	180
EV per Share	- -	17.04	11.11	9.46	8.39	9.07	7.62	6.08	42.48	40.71	22.52	6.55	18.3	21.07	6.17
TTM Sales	3	3	3	3	2	1	1	1	5	14	29	34	50	64	72
TTM EBITDA	-5	-7	-9	-7	-6	-8	-10	-14	-25	-42	-26	-27	-42	-55	-40
TTM Operating Income	-5	-7	-9	-7	-6	-8	-10	-14	-26	-43	-27	-28	-43	-57	-43
TTM Cash Flow to Firm	-3	-4	-7	-7	-6	-6	-7	-13	-19	-23	-26	-19	-37	-44	-26
TTM Free Cash Flow to Firm	-3	-4	-7	-7	-6	-6	-6	-13	-18	-22	-25	-19	-35	-34	-25

Multiples (AUD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	-12.99	-6.63	-5.59	-5.29	-8.29	-9.61	-5.37	-30.98	-40.99	-25.1	-13.04	-13.96	-13.51	-4.79
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-14	46	38	35	34	45	57	57	538	826	511	164	464	545	172
Low Price	- -	17.58	9.08	8.07	6.3	6.58	7.49	4.97	6.21	32.69	22.07	6.49	9.4	11.33	4.9
EV/Sales	- -	13.41	14.73	13.8	15.91	60.43	82.43	61.25	98.3	57.91	17.47	4.76	9.25	8.49	2.4
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	-7.6	-6.04	-9.29	-6.53	-8.89	-9.1	-4.83	-9.35	-26.02	-25.75	-9.24	-14.51	-7.42	-5.73
Price/Earnings High	- -	-9.6	-9.23	-11.7	-8.48	-13.69	-12.51	-6.75	-27.16	-40.02	-37.65	-16.02	-23.02	-12.11	-13.03
Price/Earnings Low	- -	-6.11	-4.19	-6.14	-4.63	-5.65	-6.34	-3.65	-3.13	-15.78	-18.83	-6.08	-6.73	-4.74	-2.81
Price/Book Value	- -	10.66	6.98	8.41	12.27	12.69	30.18	6.49	-3.65	-4.61	-2.8	-0.92	-1.71	-1.49	-0.35
Price/Book Value Average	- -	11.56	6.55	9.88	12.94	13.41	40.47	5.89	-1.54	-5.61	-3.09	-0.94	-1.72	-1.28	-0.68
Price/Book Value High	- -	14.61	10.02	12.45	16.8	20.66	55.65	8.24	-4.46	-8.63	-4.52	-1.63	-2.73	-2.08	-1.55
Price/Book Value Low	- -	9.3	4.54	6.53	9.17	8.52	28.22	4.46	-0.51	-3.4	-2.26	-0.62	-0.8	-0.82	-0.33
Price/Tangible Book Value	- -	6.27	4.98	7.36	10.44	9.55	15.25	4.85	27.09	12.46	5.39	2.87	10.51	-499.79	-6.46
Price/Tangible Book Value Average	- -	6.8	4.67	8.65	11.01	10.09	20.45	4.4	11.39	15.18	5.94	2.92	10.57	-428.73	-12.49
Price/Tangible Book Value High	- -	8.59	7.14	10.9	14.29	15.54	28.12	6.16	33.08	23.35	8.69	5.07	16.77	-699.15	-28.4
Price/Tangible Book Value Low	- -	5.47	3.24	5.72	7.8	6.41	14.26	3.33	3.82	9.21	4.34	1.92	4.9	-273.9	-6.13
Price/Sales	- -	15.86	18.5	15.16	16	65.31	86.63	72.87	101.99	62.94	21.23	7.03	10.18	8.33	2.01
Price/Sales Average	- -	17.2	17.36	17.83	16.88	69.02	116.18	66.17	42.86	76.67	23.41	7.16	10.24	7.15	3.89
Price/Sales High	- -	21.74	26.54	22.45	21.91	106.28	159.77	92.58	124.53	117.93	34.24	12.41	16.24	11.65	8.84
Price/Sales Low	- -	13.83	12.04	11.78	11.96	43.84	81	50.08	14.37	46.5	17.12	4.71	4.75	4.57	1.91
Price/Cash Flow	- -	-12.76	-6.56	-5.53	-5.27	-8.24	-9.13	-5.22	-29	-39.46	-23.96	-12.68	-13.43	-10.94	-4.62
Price/Cash Flow Average	- -	-13.83	-6.15	-6.5	-5.56	-8.71	-12.24	-4.74	-12.19	-48.08	-26.42	-12.91	-13.5	-9.38	-8.93
Price/Cash Flow High	- -	-17.48	-9.4	-8.19	-7.21	-13.42	-16.83	-6.64	-35.41	-73.95	-38.64	-22.38	-21.43	-15.3	-20.3
Price/Cash Flow Low	- -	-11.12	-4.27	-4.3	-3.94	-5.53	-8.53	-3.59	-4.09	-29.16	-19.32	-8.5	-6.26	-5.99	-4.38
Price/Free Cash Flow Average	- -	-14.09	-6.22	-6.57	-5.58	-8.77	-12.89	-4.88	-13.02	-49.94	-27.68	-13.28	-14.04	-11.59	-9.25
Price/Free Cash Flow High	- -	-17.8	-9.5	-8.28	-7.25	-13.5	-17.72	-6.83	-37.82	-76.81	-40.48	-23.01	-22.28	-18.91	-21.04
Price/Free Cash Flow Low	- -	-11.33	-4.31	-4.34	-3.95	-5.57	-8.99	-3.69	-4.36	-30.29	-20.24	-8.74	-6.51	-7.41	-4.54
EV/Sales Average	- -	14.75	13.59	16.47	16.79	64.86	111.97	54.56	39.18	71.65	19.65	6.66	10.64	7.64	4.39
EV/Sales High	- -	19.28	22.77	21.09	21.82	102.12	155.56	80.96	120.84	112.91	30.48	11.91	16.65	12.15	9.34
EV/Sales Low	- -	11.38	8.27	10.42	11.87	39.67	76.8	38.46	10.68	41.47	13.36	4.21	5.15	5.06	2.41
EV/EBITDA Average	2.53	-7.03	-4.04	-6.11	-5.78	-5.76	-7.91	-3.69	-8.49	-24.21	-22.25	-8.51	-12.7	-8.85	-7.82
EV/EBITDA High	2.53	-9.2	-6.78	-7.83	-7.51	-9.07	-11	-5.48	-26.19	-38.15	-34.5	-15.22	-19.87	-14.08	-16.65
EV/EBITDA Low	2.53	-5.43	-2.46	-3.87	-4.08	-3.52	-5.43	-2.6	-2.32	-14.01	-15.12	-5.38	-6.15	-5.86	-4.29
EV/EBIT Average	2.53	-7.03	-4.04	-6.11	-5.78	-5.72	-7.83	-3.66	-8.4	-23.94	-21.65	-8.33	-12.51	-8.68	-7.39
EV/EBIT High	2.53	-9.2	-6.78	-7.83	-7.51	-9	-10.88	-5.43	-25.91	-37.73	-33.57	-14.91	-19.57	-13.8	-15.73
EV/EBIT Low	2.53	-5.43	-2.46	-3.87	-4.08	-3.5	-5.37	-2.58	-2.29	-13.86	-14.72	-5.27	-6.06	-5.75	-4.05
Last Price	- -	20.16	13.96	10.39	8.44	9.8	8.01	7.23	44.08	44.24	27.37	9.69	20.15	20.68	5.17
High Price	- -	27.63	20.02	15.39	11.55	15.94	14.76	9.18	53.82	82.9	44.14	17.09	32.16	28.93	22.73
Enterprise Value Average	-14	51	35	42	35	49	78	51	214	1,022	575	229	534	491	314
Enterprise Value High	-14	66	58	53	46	76	108	75	661	1,610	891	410	835	781	669
Enterprise Value Low	-14	39	21	26	25	30	53	36	58	592	391	145	258	325	172

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	13	13	18	18	24	30	35	64	94	21	25	25	26	26	31
Diluted Weighted Avg Shares	1	3	3	4	4	5	7	9	13	20	23	25	25	26	28
Basic Weighted Avg Shares	1	3	3	4	4	5	7	9	13	20	23	25	25	26	28
Revenue per Share	2.55	1.27	0.75	0.69	0.53	0.15	0.09	0.1	0.43	0.7	1.29	1.38	1.98	2.48	2.57
EBITDA per Share	-4.1	-2.67	-2.53	-1.85	-1.53	-1.69	-1.31	-1.47	-1.99	-2.08	-1.14	-1.08	-1.66	-2.14	-1.44
Operating Income per Share	-4.1	-2.67	-2.53	-1.85	-1.53	-1.7	-1.32	-1.48	-2.02	-2.1	-1.17	-1.1	-1.68	-2.19	-1.53
Basic EPS, GAAP	-1.47	-2.88	-2.17	-1.31	-1.36	-1.16	-1.18	-1.36	-1.98	-2.07	-1.17	-1.07	-1.4	-2.39	-1.74
Basic EPS from Cont Ops	-1.47	-2.91	-2.17	-1.31	-1.36	-1.54	-1.18	-1.36	-1.98	-2.07	-1.17	-1.07	-1.4	-2.39	-1.74
Diluted EPS, GAAP	-1.47	-2.88	-2.17	-1.31	-1.36	-1.16	-1.18	-1.36	-1.98	-2.07	-1.17	-1.07	-1.4	-2.39	-1.74
Diluted EPS from Cont Ops	-1.47	-2.91	-2.17	-1.31	-1.36	-1.54	-1.18	-1.36	-1.98	-2.07	-1.17	-1.07	-1.4	-2.39	-1.74
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2.24	-1.58	-2.13	-1.88	-1.6	-1.19	-0.88	-1.38	-1.52	-1.12	-1.14	-0.76	-1.5	-1.89	-1.12
Free Cash Flow per Basic Share	-2.31	-1.61	-2.15	-1.9	-1.61	-1.2	-0.92	-1.42	-1.62	-1.16	-1.19	-0.78	-1.56	-2.25	-1.16
Cash & Equivalents per Share	10.41	3.12	2.85	0.93	0.05	0.73	0.39	1.16	1.59	3.63	4.88	3.17	3.52	1.39	0.65
Book Value per Share	10.37	1.89	2	1.24	0.69	0.77	0.27	1.11	-12.07	-9.61	-9.77	-10.5	-11.76	-13.9	-14.66
Tangible Book Value per Share	11.02	3.22	2.8	1.41	0.81	1.03	0.53	1.49	1.63	3.55	5.08	3.37	1.92	-0.04	-0.8

AVITA Medical, Inc.

Profitability (AUD)

Credit (AUD)

Liquidity (AUD)

Working Capital (AUD)

Enterprise Value (AUD)

Multiples (AUD)

Per Share Data Items (AUD)